2018
DOI: 10.1159/000491697
|View full text |Cite
|
Sign up to set email alerts
|

A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients

Abstract: Poor responders are described as those In Vitro Fertilization (IVF) patients who are failing to respond to controlled ovarian stimulation protocols. Extensive research has focused on crafting the optimal treatment. However, it appears that each approach fails to be established as effective or guaranteed towards successful management. Platelet-Rich Plasma (PRP) is a novel, highly promising approach that has been successfully applied for an array of medical issues. In this case series, we present 3 poor responde… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
65
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 65 publications
(68 citation statements)
references
References 45 publications
(30 reference statements)
1
65
0
2
Order By: Relevance
“…Using this approach, we described four poor-prognosis IVF patients (mean age 42yrs) who had been consigned to donor oocyte treatment-all produced blastocysts from their own eggs after ovarian PRP and one has since undergone thaw, transfer, and healthy term delivery [5]. Six months later, experts in Greece reported on three poorresponder IVF patients (mean age 38yrs) with similar "revolutionary" outcomes [4]. Of note, or at least one patient with a history of producing consecutive aneuploid embryos intraovarian injection of platelet-derived growth factors before IVF achieved what appeared to be a qualitative "ploidy rescue", with subsequent healthy term delivery [11].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Using this approach, we described four poor-prognosis IVF patients (mean age 42yrs) who had been consigned to donor oocyte treatment-all produced blastocysts from their own eggs after ovarian PRP and one has since undergone thaw, transfer, and healthy term delivery [5]. Six months later, experts in Greece reported on three poorresponder IVF patients (mean age 38yrs) with similar "revolutionary" outcomes [4]. Of note, or at least one patient with a history of producing consecutive aneuploid embryos intraovarian injection of platelet-derived growth factors before IVF achieved what appeared to be a qualitative "ploidy rescue", with subsequent healthy term delivery [11].…”
Section: Discussionmentioning
confidence: 99%
“…These descriptive findings would have been strengthened by comparisons with a matched control group. How ovarian PRP patients perform later in ovulation induction and IVF is now only just beginning to be studied [4,5,16]. While non-reproductive use of intraovarian PRP was outside the scope of this clinical trial, estradiol and testosterone are both ovarian modulators of female sexual and neurobehavioral response and appear to be substantially enhanced after PRP treatment [25][26][27][28].Familiarity with PRP used in other clinical settings has prompted awareness and wider acceptance of this technology by IVF patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of PRP in the reproductive context was pioneered by our team and cited by Sills and colleagues (48). Further to that, two case series have been published reporting on ovarian rejuvenation following intraovarian PRP infusion in women characterized as either peri-menopausal (49), or of poor ovarian response (50). Regarding this case report, what should be further highlighted as strengthening the cause and effect association between PRP and treatment of CE enabling pregnancy and live birth is the fact that the quality of the donated embryos that led to a miscarriage was in fact superior when compared to the quality of the embryos that actually resulted in live birth following PRP treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Although PRP has found widespread use for tissue healing, especially in areas such as ophthalmology, orthopedics and plastic surgery, there are very limited number of existing studies in the field of infertility. (Dhillon et al, 2012;Chang et al, 2015;Ronci et al, 2015;Garcia-Velasco et al, 2016;Sfakianoudis et al, 2018).…”
Section: Introductionmentioning
confidence: 99%